Moores Cancer Center at UC San Diego Health, the only
NCI-designated Comprehensive Cancer Center in San Diego, is also one of only a few cancer centers in the country with the capability to explore all facets of immunotherapy, the use of drugs that stimulate the immune system to fight cancer. Our team — led by world renowned physician-scientist
Ezra Cohen, MD — has activated several clinical trials to explore novel immune checkpoint inhibitors and tumor vaccines.
Videos from "Immunotherapy: Understanding the Hype and Hope"
Our Aug. 20, 2016, event included four education presentations on the latest exciting developments in immunotherapy.
Watch now:
What is Immunotherapy?
Immunotherapy is treatment that augments, retrains, or retargets the immune system to fight cancer. Your immune system consists of white blood cells, also called leukocytes, which help protect your body against infections and diseases. The goal of immunotherapy is to train these cells to attack cancer without harming healthy tissue.
The idea of immunotherapy has been around for a long time, but new developments promise to revolutionize the way we treat cancer.
Types of Immunotherapy
Contact Our Specialists
Clinical Trials
Spotlight on Innovation
Several patients share their stories, including Ralph Whitworth, who worked with Drs. Scott Lippman and Ezra Cohen to accelerate immunotherapy studies.
Watch Now
Hear about Rikki’s journey through diagnosis, the recommendation that he have his entire tongue removed, and finally to a clinical trial that is testing a combination of two immunotherapies.
Listen Now
By the age of 4, Matthew Haemsch had undergone 16 rounds of chemotherapy and a surgery to remove a cancerous tumor on his adrenal gland
Read More
Discovery could broaden effectiveness of emerging therapies for cancer and other diseases that are based on boosting the natural immune system response.
Read More
Experimental cellular-immunotherapy may boost body’s ability to find and destroy specific cancers.
Read More
Genetic phenomenon associated with low tumor invasiveness and longer patient survival could inform prognosis and help identify patients who would best respond to immunotherapy and other treatments.
Read More
Immune cell manipulation plus chemotherapy achieves prostate cancer remission in mouse models where chemotherapy alone fails.
Read More
View all immunotherapy news >
Support Our Immunotherapy Work
For information on how to support cancer immunotherapy, please contact Marissa Nemirofsky at mnemirofsky@ucsd.edu or 858-822-3585.
Your support will allow us to complete our new cell processing lab more quickly and dramatically accelerate our immunotherapy trials and research, delivering this transformative therapy and its life-saving results to our patients who need help now.